CDXS - Codexis to Participate in Two Investment Conferences in March
REDWOOD CITY, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment conferences:
- Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12 at 10:00 a.m. Eastern time (7:00 am Pacific time). The conference is being held at the Boston Marriott Copley Place;
- 31st Roth Conference being held March 17-19 at the Ritz-Carlton Laguna Niguel in Dana Point, Calif.
A live webcast and replay of the presentation at the Cowen and Company Health Care Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com.
Contacts:
Investors
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com